Interactions_NNS
of_IN
a_DT
transcriptional_JJ
activator_NN
in_IN
the_DT
env_NN
gene_NN
of_IN
the_DT
mouse_NN
mammary_JJ
tumor_NN
virus_NN
with_IN
activation-dependent_JJ
,_,
T_NN
cell-specific_JJ
transacting_VBG
factors_NNS
._.

The_DT
mouse_NN
mammary_JJ
tumor_NN
virus_NN
env_NN
gene_NN
contains_VBZ
a_DT
transcriptional_JJ
activator_NN
-LRB-_-LRB-
META_NN
-RRB-_-RRB-
that_WDT
can_MD
control_VB
transcription_NN
of_IN
the_DT
adjacent_JJ
long_JJ
terminal_JJ
repeat_NN
region_NN
._.

Transcriptional_JJ
control_NN
by_IN
META_NN
parallels_VBZ
that_DT
of_IN
several_JJ
lymphokine_NN
genes_NNS
,_,
being_VBG
specific_JJ
to_TO
T_NN
cells_NNS
,_,
dependent_JJ
on_IN
their_PRP$
activation_NN
,_,
and_CC
inhibited_VBN
by_IN
the_DT
immunosuppressive_JJ
drug_NN
cyclosporine_NN
-LRB-_-LRB-
CsA_NN
-RRB-_-RRB-
._.

DNase_NN
I_NN
footprinting_NN
indicated_VBD
that_IN
nuclear_JJ
factors_NNS
from_IN
activated_VBN
T_NN
lymphocytes_NNS
bound_VBD
a_DT
promoter-proximal_JJ
site_NN
,_,
META_NN
-LRB-_-LRB-
P_NN
-RRB-_-RRB-
,_,
and_CC
a_DT
promoter-distal_JJ
site_NN
,_,
META_NN
-LRB-_-LRB-
D_NN
+_NN
-RRB-_-RRB-
,_,
within_IN
the_DT
400-base_JJ
pair_NN
META_NN
region_NN
._.

Nuclear_JJ
factors_NNS
from_IN
unstimulated_JJ
,_,
but_CC
not_RB
from_IN
activated_VBN
cells_NNS
,_,
bound_VBD
a_DT
site_NN
,_,
META_NN
-LRB-_-LRB-
D_NN
-_NN
-RRB-_-RRB-
,_,
adjacent_JJ
to_TO
META_NN
-LRB-_-LRB-
D_NN
+_NN
-RRB-_-RRB-
._.

META_NN
-LRB-_-LRB-
D_NN
+_NN
-RRB-_-RRB-
directed_VBD
transcription_NN
of_IN
a_DT
linked_VBN
luciferase_NN
gene_NN
,_,
and_CC
gel_NN
shift_NN
analysis_NN
revealed_VBD
binding_NN
of_IN
inducible_JJ
,_,
CsA-sensitive_JJ
T_NN
cell_NN
factors_NNS
,_,
in_IN
parallel_NN
with_IN
transfection_NN
results_NNS
._.

Authentic_JJ
NFAT_NN
and_CC
NF-kappaB_NN
targets_NNS
did_VBD
not_RB
compete_VB
for_IN
the_DT
META_NN
-LRB-_-LRB-
D_NN
+_NN
-RRB-_-RRB-
binding_NN
factor_NN
-LRB-_-LRB-
s_NNS
-RRB-_-RRB-
._.

The_DT
SV40_NN
core_NN
sequence_NN
competed_VBD
for_IN
META_NN
-LRB-_-LRB-
D_NN
+_NN
-RRB-_-RRB-
binding_VBG
factors_NNS
,_,
but_CC
META_NN
-LRB-_-LRB-
D_NN
+_NN
-RRB-_-RRB-
failed_VBD
to_TO
compete_VB
for_IN
the_DT
complexes_NNS
obtained_VBN
with_IN
the_DT
SV40_NN
probe_NN
._.

Our_PRP$
results_NNS
,_,
taken_VBN
together_RB
,_,
indicate_VBP
that_IN
META_NN
-LRB-_-LRB-
D_NN
+_NN
-RRB-_-RRB-
is_VBZ
a_DT
novel_JJ
transcriptional_JJ
enhancer_NN
element_NN
that_WDT
is_VBZ
similar_JJ
in_IN
its_PRP$
cell-type_JJ
specificity_NN
,_,
activation_NN
dependence_NN
,_,
and_CC
CsA_NN
sensitivity_NN
to_TO
the_DT
NFAT_NN
element_NN
._.

It_PRP
may_MD
be_VB
relevant_JJ
to_TO
the_DT
role_NN
of_IN
MMTV_NN
in_IN
expression_NN
of_IN
Mls_NN
antigens_NNS
or_CC
the_DT
induction_NN
of_IN
T_NN
cell_NN
lymphomas_NNS
._.

